PAPPA and acute coronary syndrome: Further, PAPP-A levels predict cardiovascular events in troponin-negative patients with suspected acute coronary syndrome [3] and higher levels of circulating PAPP-A are associated with more extensive coronary artery disease [13] as well as with plaque inflammation and echogenicity [14].